Furthermore, studies on HCC revealed that EGF drives the nuclear translocation of LIMK1 by activating the interaction between p-ERK and LIMK1 and that nuclear LIMK1 directly binds to the promoter region of c-myc to stimulate c-myc transcription, thereby promoting HCC progression [219]. Here, EGF is linked to hepatocellular carcinoma.